Biognosys launches integrated large-scale proteomics service in the US
Industrialized Discovery combines sample preparation, timsTOF mass spectrometry and automated analysis; the service was announced on 10 November for US operations.
On 10 November 2026, Biognosys Group announced the launch of Industrialized Discovery, an integrated quantitative proteomics service. It is currently available through the group's US operations and targets large sample series in drug discovery and translational research. The announcement gives no launch date for Japan.
According to the company, the workflow combines PreOmics iST and iST-S sample preparation, Bruker timsTOF mass spectrometry, and automated analysis with Biognosys Spectronaut and OmicsFlow. Quality control is embedded across preparation, measurement, processing and reporting. The company reports more than 10,000 protein identifications from 50,000 HEK-293 cells and indicative turnaround times of under three weeks for 100 samples and under ten weeks for 1,000. These are company-reported figures, not a guarantee for every sample type or study design.
Laboratories considering outsourced or in-house large-scale protein quantification should confirm sample compatibility, required depth, batch and site comparability, quality-control metrics and deliverable data formats. This is a service launch, not a new official test method or standard. Availability, pricing and performance for specific studies need confirmation with the provider.